Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMBRISENTAN vs BOSENTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMBRISENTAN vs BOSENTAN: Safety Overview

Metric AMBRISENTAN BOSENTAN
Total FAERS Reports 86,197 19,581
Deaths Reported 10,291 4,346
Death Rate 11.9% 22.2%
Hospitalizations 32,910 8,862
Average Patient Age 59.5 yrs 52.5 yrs
% Female Patients 76.1% 73.2%
FDA Approval Date Apr 10, 2019 Apr 26, 2019
Manufacturer Sigmapharm Laboratories, LLC Actelion Pharmaceuticals US, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription